Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review. JOHMPE [Internet]. 27. februar 2025 [henvist 24. august 2026];3(1). Tilgængelig hos: https://shmpublisher.com/index.php/johmpe/article/view/547